Reimbursement News
Reimbursement news and insurance coverage updates.
CMS Contractor Proposes Noncoverage of Castle Biosciences Skin Cancer Test
The contractor said that the test has not yet demonstrated definitive value above the combination of available clinical, pathological, and staging criteria in accurate risk stratification.
Bills in the House and Senate would establish Part B coverage for pharmacy testing for diseases like COVID-19, flu, respiratory syncytial virus, and strep throat.
Thermo Fisher Scientific Gets FDA Clearance for Preeclampsia Risk Assessment Assays
A ratio of the two biomarkers detected by the 30-minute clinical chemistry assays can be used for prognosis and treatment of preeclampsia.
UK's NICE Recommends Genetic Testing for Therapy Selection in Stroke Patients
Clopidogrel is less effective at preventing subsequent strokes in patients with certain variations in the CYP2C19 gene and testing could aid treatment selection.
Guardant Health Secures New Commercial Payor Coverage for Liquid Biopsy Cancer Profiling Test
With new coverage from Anthem Blue Cross and Blue Shield, Aetna, and Humana, the firm's Guardant360/Guardant360 CDx assay is now covered by all major commercial health insurers.